+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Insulin lispro lowers the incidence of severe hypoglycemia, without a detrimental effect on glycemic control, in those individuals with type 1 diabetes at high risk of severe hypoglycemia



Insulin lispro lowers the incidence of severe hypoglycemia, without a detrimental effect on glycemic control, in those individuals with type 1 diabetes at high risk of severe hypoglycemia



Diabetes 48(Suppl. 1): A122




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035150101

Download citation: RISBibTeXText


Related references

Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine. Nutrition, Metabolism, and Cardiovascular Diseases 20(7): 519-526, 2010

Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 21(10): 1726-1731, 1998

Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets. Experimental and Clinical Endocrinology and Diabetes 113(4): 199-204, 2005

Improvement of glycemic control without severe hypoglycemia in a type 1 diabetes patient undergoing hemodialysis after a change from insulin glargine to insulin degludec. Journal of Diabetes Investigation 7(5): 805-806, 2017

Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study. Diabetes Technology and Therapeutics 12(7): 517-521, 2010

Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus. Pediatrics 115(5): 1320-1324, 2005

Continuous subcutaneous insulin infusion reduces severe hypoglycemia in children with type 1 diabetes mellitus without compromising overall glycemic control. Pediatric Research 47(4 Part 2): 132A, 2000

Nocturnal continuous glucose monitoring: accuracy and reliability of hypoglycemia detection in patients with type 1 diabetes at high risk of severe hypoglycemia. Diabetes Technology and Therapeutics 15(5): 371-377, 2013

Quantifying the Trade-off Between Improved Glycemic Control and Severe Hypoglycemia Risk in Patients with Type 1 Diabetes: A Health Economic Analysis in the Uk. Value in Health 20(9): A486-A487, 2017

Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial. Diabetes Technology and Therapeutics 20(3): 247-256, 2018

Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type 1 diabetes. Pediatric Diabetes 9(4 Pt 2): 382-387, 2008

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3). Diabetes Technology and Therapeutics 20(4): 274-284, 2018

Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. JAMA 318(14): 1358-1366, 2017

Hypoglycemia unawareness a risk factor for severe hypoglycemia and cognitive impairment in insulin treated diabetes. Diabetologia 34(Suppl. 2): A186, 1991

Association of diabetic ketoacidosis, severe hypoglycemia and glycemic control among children and young adults with type 1 diabetes mellitus treated with premixed versus basal-bolus insulin therapy. Biomedical Journal 41(6): 348-355, 2019